The only patient with MD-IPMN without an activating GNAS mutation in the aspirated MPD fluid initially refused surgery and developed biopsy-confirmed MD-IPMN-associated metastatic pancreatic cancer 13 months later. This evidence concerns the gene GNAS and Menkes disease.